| Income Statement | |
| Net sales | 416.05M |
| Cost of sales (1) | |
| Gross profit | 200.43M |
| Operating expenses: | |
| Research and development (1) | 71.38M |
| Selling, general and administrative (1) | 69.37M |
| Special charges | 2.56M |
| Total operating expenses | 183.02M |
| Operating income | 17.41M |
| Losses on equity method investments | -229K |
| Other income (expense): | |
| Interest income | 3.81M |
| Interest expense | -11.08M |
| Other, net | -228K |
| Income from continuing operations before income taxes | |
| Income tax provision | -481K |
| Net income from continuing operations | |
| Discontinued operations: | |
| Loss from discontinued operations before income taxes | |
| Income tax provision | |
| Net loss from discontinued operations | |
| Net income | 10.17M |
| Basic net income per common share - continuing operations | |
| Basic net loss per common share - discontinued operations | |
| Basic net income per common share | 0.05 |
| Diluted net income per common share - continuing operations | |
| Diluted net loss per common share - discontinued operations | |
| Diluted net income per common share | 0.05 |
| Dividends declared per common share | 0.35 |
| Basic common shares outstanding | 194.96M |
| Diluted common shares outstanding | 204.41M |